228 related articles for article (PubMed ID: 10803976)
1. GTP, an inhibitor of transglutaminases, is hydrolyzed by tissue-type transglutaminase (TGase 2) but not by epidermal-type transglutaminase (TGase 3).
Hitomi K; Ikura K; Maki M
Biosci Biotechnol Biochem; 2000 Mar; 64(3):657-9. PubMed ID: 10803976
[TBL] [Abstract][Full Text] [Related]
2. Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II.
Feng JF; Readon M; Yadav SP; Im MJ
Biochemistry; 1999 Aug; 38(33):10743-9. PubMed ID: 10451369
[TBL] [Abstract][Full Text] [Related]
3. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase.
Lai TS; Hausladen A; Slaughter TF; Eu JP; Stamler JS; Greenberg CS
Biochemistry; 2001 Apr; 40(16):4904-10. PubMed ID: 11305905
[TBL] [Abstract][Full Text] [Related]
4. GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket.
Iismaa SE; Wu MJ; Nanda N; Church WB; Graham RM
J Biol Chem; 2000 Jun; 275(24):18259-65. PubMed ID: 10747935
[TBL] [Abstract][Full Text] [Related]
5. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.
Iismaa SE; Chung L; Wu MJ; Teller DC; Yee VC; Graham RM
Biochemistry; 1997 Sep; 36(39):11655-64. PubMed ID: 9305955
[TBL] [Abstract][Full Text] [Related]
6. GTP is required to stabilize and display transamidation activity of transglutaminase 2.
Jeon JH; Cho SY; Kim CW; Shin DM; Kweon JC; Choi KH; Park SC; Kim IG
Biochem Biophys Res Commun; 2002 Jun; 294(4):818-22. PubMed ID: 12061780
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition.
Jeong KC; Ahn KO; Lee BI; Lee CH; Kim SY
J Cancer Res Clin Oncol; 2010 Jan; 136(1):143-50. PubMed ID: 19655169
[TBL] [Abstract][Full Text] [Related]
8. GTP-binding-defective forms of tissue transglutaminase trigger cell death.
Datta S; Antonyak MA; Cerione RA
Biochemistry; 2007 Dec; 46(51):14819-29. PubMed ID: 18052077
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of rat brain transglutaminase.
Ohashi H; Itoh Y; Birckbichler PJ; Takeuchi Y
J Biochem; 1995 Dec; 118(6):1271-8. PubMed ID: 8720146
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
Case A; Stein RL
Biochemistry; 2007 Jan; 46(4):1106-15. PubMed ID: 17240993
[TBL] [Abstract][Full Text] [Related]
11. The emerging structural understanding of transglutaminase 3.
Ahvazi B; Boeshans KM; Rastinejad F
J Struct Biol; 2004 Aug; 147(2):200-7. PubMed ID: 15193648
[TBL] [Abstract][Full Text] [Related]
12. Development of a mechanism-based assay for tissue transglutaminase--results of a high-throughput screen and discovery of inhibitors.
Case A; Ni J; Yeh LA; Stein RL
Anal Biochem; 2005 Mar; 338(2):237-44. PubMed ID: 15745743
[TBL] [Abstract][Full Text] [Related]
13. Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis.
Shin DM; Jeon JH; Kim CW; Cho SY; Kwon JC; Lee HJ; Choi KH; Park SC; Kim IG
J Biol Chem; 2004 Apr; 279(15):15032-9. PubMed ID: 14752105
[TBL] [Abstract][Full Text] [Related]
14. Ca2+: a stabilizing component of the transglutaminase activity of Galphah (transglutaminase II).
Lee SC; Kim JH; Park ES; Kim DK; Kim YG; Yun HY; Kwon NS; Im MJ; Baek KJ
Mol Cells; 2003 Dec; 16(3):285-90. PubMed ID: 14744016
[TBL] [Abstract][Full Text] [Related]
15. A novel therapeutic target in inflammatory uveitis: transglutaminase 2 inhibitor.
Sohn J; Chae JB; Lee SY; Kim SY; Kim JG
Korean J Ophthalmol; 2010 Feb; 24(1):29-34. PubMed ID: 20157411
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 induces nitric oxide synthesis in BV-2 microglia.
Park KC; Chung KC; Kim YS; Lee J; Joh TH; Kim SY
Biochem Biophys Res Commun; 2004 Oct; 323(3):1055-62. PubMed ID: 15381106
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human recombinant transglutaminase 1 purified from baculovirus-infected insect cells.
Hitomi K; Yamagiwa Y; Ikura K; Yamanishi K; Maki M
Biosci Biotechnol Biochem; 2000 Oct; 64(10):2128-37. PubMed ID: 11129585
[TBL] [Abstract][Full Text] [Related]
19. Identification of the eukaryotic initiation factor 5A as a retinoic acid-stimulated cellular binding partner for tissue transglutaminase II.
Singh US; Li Q; Cerione R
J Biol Chem; 1998 Jan; 273(4):1946-50. PubMed ID: 9442029
[TBL] [Abstract][Full Text] [Related]
20. Identification of mammalian-type transglutaminase in Physarum polycephalum. Evidence from the cDNA sequence and involvement of GTP in the regulation of transamidating activity.
Wada F; Nakamura A; Masutani T; Ikura K; Maki M; Hitomi K
Eur J Biochem; 2002 Jul; 269(14):3451-60. PubMed ID: 12135484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
